Steven Cohen’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
Other funds holding SYRE
Steven Cohen's SYRE Position: Q3 2026 in Review
Steven Cohen opened a new position in Spyre Therapeutics (SYRE) in Q3 2026: 356,923 shares worth $31.8M. The stake represents 0.04% of the portfolio and ranks #661 among its holdings. This is a return to the name: Steven Cohen previously reported a position in SYRE as recently as Q4 2025.
Steven Cohen first reported a position in SYRE in Q3 2018 and has held it in 6 quarters since. 285 funds tracked by Wall St. Rank hold SYRE as of Q3 2026.
- Steven Cohen held 356,923 shares of Spyre Therapeutics worth $31.8M as of Q3 2026.
- Spyre Therapeutics was a new Steven Cohen position in Q3 2026.
- Spyre Therapeutics made up 0.04% of Steven Cohen's portfolio in Q3 2026, its #661 holding.
- Steven Cohen first reported a position in Spyre Therapeutics in Q3 2018 and has held it in 6 quarters since.
- 285 funds tracked by Wall St. Rank held Spyre Therapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.